Kerala Ayurveda Board of Directors

Get the latest insights into the leadership at Kerala Ayurveda. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ramesh Vangal Chairman
Dr. Kunjupanicker Anilkumar Whole Time Director
Mr. Gokul Patnaik Director
Mr. Anand Subramanian Director
Mr. Rajesh Sharma Independent Director
Mr. Subramaniam Krishnamurthy Independent Director
Ms. Shilpa Kiran Gududur Independent Director
Mr. Harish Kuttan Menon Independent Director

Kerala Ayurveda Share price

KERALAYUR

465.7

4.00 (-0.85%)
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

474.30

Today's Low

455.55

52 Week Low

250.00

52 Week High

625.00

The current prices are delayed, login to your account for live prices

Kerala Ayurveda FAQs

The board at Kerala Ayurveda consists of experienced professionals, including Mr. Ramesh Vangal , Dr. Kunjupanicker Anilkumar , and others, overseeing the company’s strategic and corporate governance.

Directors at Kerala Ayurveda are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ramesh Vangal is the current chairman at Kerala Ayurveda.

Executive directors at Kerala Ayurveda are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Kerala Ayurveda adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Kerala Ayurveda, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.